Free Trial

Polarean Imaging (POLX) Competitors

Polarean Imaging logo
GBX 1.02 +0.03 (+2.50%)
As of 04/17/2025 12:57 PM Eastern

POLX vs. IUG, CREO, NCYT, IHC, AVO, RUA, MHC, SUN, BELL, and DEMG

Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Intelligent Ultrasound Group (IUG), Creo Medical Group (CREO), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry.

Polarean Imaging vs.

Polarean Imaging (LON:POLX) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, community ranking, media sentiment, earnings, risk and institutional ownership.

Intelligent Ultrasound Group has a net margin of -34.56% compared to Polarean Imaging's net margin of -1,333.97%. Intelligent Ultrasound Group's return on equity of -37.71% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean Imaging-1,333.97% -86.11% -32.28%
Intelligent Ultrasound Group -34.56%-37.71%-13.51%

Polarean Imaging has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500.

Polarean Imaging received 23 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Polarean ImagingOutperform Votes
23
67.65%
Underperform Votes
11
32.35%
Intelligent Ultrasound GroupN/AN/A

12.1% of Polarean Imaging shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 39.3% of Polarean Imaging shares are owned by insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Intelligent Ultrasound Group has higher revenue and earnings than Polarean Imaging. Polarean Imaging is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£5.21M2.89-£69.44M-£3.89-0.26
Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A

In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.

Company Overall Sentiment
Polarean Imaging Neutral
Intelligent Ultrasound Group Neutral

Summary

Intelligent Ultrasound Group beats Polarean Imaging on 7 of the 10 factors compared between the two stocks.

Get Polarean Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLX vs. The Competition

MetricPolarean ImagingMedical Devices IndustryMedical SectorLON Exchange
Market Cap£15.04M£3.03B£5.30B£2.48B
Dividend YieldN/A2.45%5.45%4.96%
P/E Ratio-0.2663.5921.86129.79
Price / Sales2.89113.75380.67232,228.16
Price / Cash4.9315.9938.2628.16
Price / Book0.313.646.454.40
Net Income-£69.44M£126.02M£3.22B£5.83B
1 Month Performance-17.34%-7.13%-9.74%-1.33%
1 Year Performance-73.72%-13.44%11.49%40.92%

Polarean Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POLX
Polarean Imaging
N/AGBX 1.03
+2.5%
N/A-73.3%£15.04M£5.21M-0.2628Gap Up
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
CREO
Creo Medical Group
N/AGBX 9.85
flat
N/A-72.3%£39.82M£33.87M-1.56279
NCYT
Novacyt
N/AGBX 43.10
+1.2%
N/A-36.3%£29.78M£18.12M-0.79120Positive News
IHC
Inspiration Healthcare Group
N/AGBX 16.65
-0.6%
N/A-43.2%£14.42M£42.87M-1.14224
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.45
+1.7%
N/A+1.6%£7.10M£4.05M-2.6748Gap Down
MHC
MyHealthChecked
N/AGBX 13.12
-6.3%
N/A+27.2%£6.83M£9.43M-6.5416Gap Up
SUN
Surgical Innovations Group
N/AGBX 0.47
-6.8%
N/A-9.1%£4.35M£12.54M-21.1180Gap Up
BELL
Belluscura
N/AGBX 0.71
-4.9%
N/A-92.3%£1.80M£2.87M-0.0824Gap Down
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume

Related Companies and Tools


This page (LON:POLX) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners